Jacobs & Co’s Elanco Animal Health ELAN Stock Holding History

Jacobs & Co’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,332	Closed	-$208K	–	126
2021 Q4	$208K	Sell	7,332 -356	-5%	-$11.1K	0.02%	120
2021 Q3	$245K	Hold	7,688	–	–	0.03%	110
2021 Q2	$266K	Sell	7,688 -369	-5%	-$12.2K	0.03%	107
2021 Q1	$237K	Sell	8,057 -3,449	-30%	-$106K	0.03%	109
2020 Q4	$352K	Sell	11,506 -943	-8%	-$28.8K	0.05%	98
2020 Q3	$347K	Sell	12,449 -3,759	-23%	-$95.3K	0.05%	94
2020 Q2	$347K	Sell	16,208 -342	-2%	-$7.55K	0.06%	96
2020 Q1	$370K	Sell	16,550 -184	-1%	-$5.04K	0.07%	98
2019 Q4	$492K	Sell	16,734 -253	-1%	-$6.88K	0.07%	98
2019 Q3	$451K	Sell	16,987 -445	-3%	-$13.3K	0.07%	102
2019 Q2	$589K	Sell	17,432 -1,028	-6%	-$33.4K	0.1%	99
2019 Q1	$592K	Buy	+18,460	New	+$568K	0.1%	101

Other funds holding ELAN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jacobs & Co's ELAN Position: Q1 2022 in Review

Jacobs & Co sold out of Elanco Animal Health (ELAN) in Q1 2022, closing a stake of 7,332 shares — an estimated $208K sold.

Jacobs & Co first reported a position in ELAN in Q1 2019 and held it in 12 quarters. The position peaked at $592K in Q1 2019. 472 funds tracked by Wall St. Rank hold ELAN as of Q1 2022.

Jacobs & Co reported no remaining Elanco Animal Health position as of Q1 2022 after selling out during the quarter.
Jacobs & Co sold 7,332 Elanco Animal Health shares in Q1 2022, an estimated $208K.
Jacobs & Co first reported a position in Elanco Animal Health in Q1 2019 and held it in 12 quarters.
Jacobs & Co's Elanco Animal Health position peaked at $592K in Q1 2019.
472 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2022.

Based on Jacobs & Co's 13F filing for Q1 2022, filed 14 Apr 2022.